ArticleEuropean journal of clinical pharmacology2017

Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Malcolm Boyce et al.PubMed ↗Publisher ↗

No numbers read from the abstract.